BioPharm America is where biotech industry partnerships get started.
Based on the same winning formula used in EBD Group’s distinguished European partnering conferences BIO-Europe and BIO-Europe Spring®, BioPharm America is expected to become the premier stand-alone bio-pharma partnering event in North America. With a clear focus on generating one-to-one meetings for attendees, BioPharm America offers an unrivalled opportunity for participants across the entire biotech value-chain to identify and enter into strategic relationships.
BioPharm America attracts top executives from biotech, large and mid-sized pharmaceutical companies, the financial sector, world renown research institutions and a variety of industry related service firms. As part of the EBD family of events, which includes the world’s largest stand alone biotech partnering conference BIO-Europe, BioPharm America applies a unique and proven model for helping companies get partnerships started.
Long term goals for BioPharm America
|EBD’s objective is to turn BioPharm America into a major American partnering event, reaching the size of its European counterparts. This year’s BIO-Europe attracted 2,200 delegates from 47 different countries. A total of 8,600 one-to-one partnering meetings were conducted during the event. |
Conference goals for BioPharm America 2008
- Total attendees: 400+ top level and business development executives
- One-to-one partnering meetings: 600+
- Number of presenting companies: 50